At a glance
- Originator CJ Corporation
- Class Antibacterials
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Legionnaires' disease
Most Recent Events
- 21 May 2001 Profile reviewed but no significant changes made
- 04 Aug 1998 No-Development-Reported for Legionnaires' disease in South Korea (Unknown route)
- 22 Jan 1996 Preclinical development for Legionnaires' disease in South Korea (Unknown route)